New treatment may dramatically improve survival for those with deadly brain cancer
LOS ANGELES — High-grade astrocytoma, which includes glioblastoma, is a fast-growing, aggressive brain cancer that often returns after the tumor is removed, making it difficult to treat. Patients…
Read the full articleYou might also wanna read
Non-lytic viral immunotherapy induces long-term glioblastoma survival and tumor-specific immunity without eliciting an antiviral response
A groundbreaking study unveils an RRV delivering IL-15 superagonist to glioblastoma, halting growth, extending survival, and boosting immune
Clinical trial explores high-dose vitamin B3 as potential treatment for glioblastoma brain cancer
A clinical trial is exploring whether high doses of vitamin B3 could give patients with glioblastoma a better chance against the aggressive
Blood-brain barrier-like vascular gate identified as key driver of immunotherapy resistance in small cell lung cancer
A blood-brain barrier-like vascular gate in small cell lung cancer and other neuroendocrine cancers blocks immune cells and drives resistanc
Personalized glioblastoma vaccine shows safety and survival promise in phase 1 trial
A new clinical trial has found that a personalized vaccine to treat glioblastoma is safe and could potentially improve outcomes.
futurity.org·1mo ago
La inmunoterapia posquirúrgica ayudó a las personas con cáncer de vejiga de riesgo alto a vivir sin cáncer por más tiempo
En un estudio del NCI, se observó que administrar pembrolizumab a los pacientes después de la cirugía para el cáncer de vejiga con invasión
A Study of HF1K16 Combined With Bevacizumab in Patients With Recurrent or Progressive Glioma
Conditions : Glioma; Adult Interventions : Drug: HF1K16 Sponsors : HighField Biopharmaceuticals Corporation Not yet recruiting
Comments
Sign in to join the conversation.
No comments yet. Be the first.